News

April 15, 2015 Europe grants patent for ChromaCon N-Rich process

Press release. N-Rich is a two column chromatographic process, offering advantages for enriching and purifying minor compounds amidst an excess of other compounds.

Read more

March 2, 2015 ChromaCon sponsors first Workshop on Continuous Chromatography

Press release. The workshop is organized by ETH Zurich and allows the participants to obtain a deep insight into processes and systems as well as practical hands-on experiments.

Read more

February 10, 2015 Groundbreaking synthetic fermentation technology licensed by ChromaCon

Press release. ChromaCon acquires exclusive license for a groundbreaking technology for the generation of stable affinity molecules.

Read more

February 2, 2015 Japan grants patent for ChromaCon N-Rich process

Press release. ChromaCon adds N-Rich patent in a major Asian market to its growing patent portfolio.

Read more

November 18, 2014 Japan grants patent for ChromaCon’s CaptureSMB process

Press release. ChromaCon adds CaptureSMB® patent in a major Asian market to its growing patent portfolio.

Read more

September 29, 2014 ChromaCon and LEWA sign License and Technical Collaboration Agreement

Press release. The agreement covers intellectual property relating to GMP scale up of cyclic and continuous processing of biopharmaceuticals.

Read more

May 20, 2014 International Symposium on Continuous Manufacturing of Pharmaceuticals

ChromaCon will be participating in the International Symposium on Continuous Manufacturing of Pharmaceuticals to be held at MIT (Cambridge, MA, USA) on May 20-21, 2014.

Read more

February 14, 2013 JSR Corporation and ChromaCon AG announce strategic partnership

Press release. The companies started worldwide commercial collaboration activities to promote ChromaCon’s MCSGP and CaptureSMB chromatographic process technologies.

Read more

May 16, 2011 ChromaCon and Merus Biopharmaceuticals awared with Eurostars grant

Press release. €1.8 million were awarded towards the discovery and development of bispecific antibodies for the treatment of breast cancer.

Read more

April 1, 2010 Novo Nordisk and ChromaCon jointly present results of MCSGP study

The preparative RP-purification of insulin with the MCSGP-technology was reported at the RECOVERY-2010 conference as oral contribution

Read more
91 - 100 von 102